Alpa Laboratories (NSE:ALPA) FFO


NSE:ALPA Alpa Laboratories Ltd NSE:ALPA
75 GF Score
Price ₹68.50
GF Value ₹91.65
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Alpa Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

NSE:ALPA
75GF Score
Alpa Laboratories Ltd NSE:ALPA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alpa Laboratories (NSE:ALPA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpa Laboratories stock appears to be undervalued. The current stock price of ₹68.50 is trading 25.3% below its estimated GF Value™ of ₹91.65. GuruFocus considers Alpa Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALPA:

  • FFO:
  • GF Value™: ₹91.65 vs. price of ₹68.50 (25.3% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the NSE:ALPA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpa Laboratories Business Description

Other Exchanges 532878:India
Address 33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the drug and chemical business segment. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.
75GF Score

Get the complete analysis for NSE:ALPA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.50
Price
₹91.65
GF Value